Description
PRINCIPIO ACTIVO: DESVENLAFAXINA SUCCINATO
SUTENT® 25 mg es un medicamento de uso oral que contiene Sunitinib
FABRICANTE: GLAXO SMITH KLINE
Cáncer colorrectal metastásico RAS tipo salvaje
VECTIBIX® 100 mg es un medicamento antineoplásico que contiene panitumumab
LOC EUCERIN HYALURON FILLER 30ML SKN IMAGEN PRINCIPIO ACTIVO: DESVENLAFAXINA SUCCINATO30 ML Gel Envase
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
